Results 181 to 190 of about 261,257 (360)

Elevated plasma aldosterone-to-renin ratio as a potential risk marker of adverse left ventricular remodeling: a cross-sectional study. [PDF]

Front Med (Lausanne)
Xu M, Wei Y, Li M, Mo Z, Yan B.
europepmc   +1 more source

The modeling and simulation of feedback control systems [PDF]

A brief description of the principles of mathematical models and their development is given.
Leonard, J. I.
core   +1 more source

Risk of acute pancreatitis with DPP‐4 inhibitors versus SGLT2 inhibitors in medication‐naïve individuals with diabetes: A target trial emulation

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims We investigated whether dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use was associated with a higher risk of acute pancreatitis compared with sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in antidiabetic medication‐naïve individuals.
Takashi Tatewaki, Akira Okada, Yuya Kimura, Hideo Yasunaga   +3 more
wiley   +1 more source

Rehabilitation of patients with stroke: summary of SIGN guidance [PDF]

, 2010
Barber, M., Chung, C., Gillespie, D., James, R., Ramsay, S., Smith, L.N.   +5 more
core   +1 more source

SGLT2 inhibitors and mortality in older adults with diabetic kidney disease: A target trial emulation study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Randomized controlled trials on sodium‐glucose cotransporter 2 (SGLT2) inhibitors have yielded inconsistent findings regarding mortality benefits. It remains unclear whether, and in which subgroups, SGLT2 inhibitors confer survival benefits in older adults with diabetic kidney disease (DKD).
Tatsuhiko Azegami, Hidehiro Kaneko, Akira Okada, Yuta Suzuki, Toshiyuki Ko, Kazuki Aoyama, Takashin Nakayama, Yuya Kimura, Katsuhiko Fujiu, Norifumi Takeda, Hiroyuki Morita, Takashi Yokoo, Koichi Node, Masaomi Nangaku, Norihiko Takeda, Hideo Yasunaga, Kaori Hayashi   +16 more
wiley   +1 more source

Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation [PDF]

, 2020
Javier Campos, Rodrigo Pacheco
openalex   +1 more source

Renin; renin-angiotensin system (RAS) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Sotagliflozin, an inhibitor of sodium‐glucose co‐transporter (SGLT)‐1 and 2, reduces albuminuria, slows GFR decline, and may have diuretic and osmoregulatory effects. The effect of sotagliflozin added to insulin was assessed on markers of neurohormone activation and volume homeostasis in patients with type 1 diabetes (T1D).
Massimo Nardone, Erik Moedt, Hiddo J. L. Heerspink, Michael J. Davies, Manon Girard, David Z. I. Cherney, Marcel H. A. Muskiet   +6 more
wiley   +1 more source

Risk of Hypertension and Chronic Kidney Disease Following Aldosterone Dysregulation. [PDF]

Am J Hypertens
Townsend RR, Agiro A, Luan S, Brzozowski K, Moyneur E, Tetreault-Langlois P, Huang J.   +6 more
europepmc   +1 more source

Structure of the human renin gene.

, 1984
Hitoshi Miyazaki, Akiyoshi Fukamizu, Shigehisa Hirose, Takashi Hayashi, Hitoshi Hori, Hiroaki Ohkubo, Shigetada Nakanishi, K Murakami   +7 more
openalex   +2 more sources